HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Gallo Stampino Selected Research

ascrinvacumab

1/2016Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Gallo Stampino Research Topics

Disease

3Neoplasms (Cancer)
01/2016 - 01/2006
2Disease Progression
01/2016 - 11/2014
1Hepatocellular Carcinoma (Hepatoma)
01/2016

Drug/Important Bio-Agent (IBA)

2Monoclonal AntibodiesIBA
01/2016 - 11/2014
2Biological ProductsIBA
11/2014 - 01/2006
1ascrinvacumabIBA
01/2016
1Activin Receptors (Activin Receptor)IBA
01/2016
1Biomarkers (Surrogate Marker)IBA
01/2016
1Immunoglobulin G (IgG)IBA
11/2014
1PF-04605412IBA
11/2014
1IntegrinsIBA
11/2014
1CytokinesIBA
11/2014
1Contrast MediaIBA
01/2006
1Bromodeoxyuridine (BrdU)IBA
01/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2006
1Pharmaceutical PreparationsIBA
01/2006

Therapy/Procedure

1Therapeutics
01/2016